期刊文献+

经皮冠状动脉介入治疗术后急性支架内血栓形成原因及治疗策略解析1例 被引量:1

下载PDF
导出
摘要 急性支架内血栓形成是经皮冠状动脉介入治疗(percutaneous coronary intervention,PCI)的严重并发症之一,虽然发生率并不高,但是具有发病急,预后不良等特点。本文将报道1例典型的急性支架内血栓病例,并对其形成原因及治疗策略进行解析。
出处 《中国介入心脏病学杂志》 2015年第11期658-660,共3页 Chinese Journal of Interventional Cardiology
  • 相关文献

参考文献6

  • 1D'Ascenzo F, Bollati M, Clementi F, et al. Incidence and predictors of coronary stent thrombosis: evidence from an international collaborative meta-analysis including 30 studies, 221,066 patients, and 4276 thromboses. Int J Cardiol,2013, 167:575-584.
  • 2张燕,任艺虹,周超飞,张庆考,刘国树,刘陪沛.经皮冠状动脉介入治疗术后急性、亚急性支架内血栓形成的危险因素分析[J].中国循环杂志,2013,28(1):17-20. 被引量:33
  • 3Hobson AR, Qureshi Z, Banks P. Gender and responses to aspirin and clopidogrel: insights using short thrombelastography. Cardiovasc Therapy,2009,27 : 246-252.
  • 4刘然,师树田,索旻,王成钢,原琳,祖晓麟,张新勇,阙斌,艾辉,王春梅,聂绍平.对氯吡格雷低反应患者换用替格瑞洛后的有效性与安全性评价[J].中国介入心脏病学杂志,2014,22(1):12-17. 被引量:52
  • 5Steg PG, James S, Harrington RA, et al. Ticagrelor versus elopidogrel in patients with ST-elevation acute coronary syndromes intended for reperfusion with primary percutaneous coronary intervention: A Platelet Inhibition and Patient Outcomes (PLATO) trial subgroup analysis. Circulation, 2010,12 : 2131 - 2141.
  • 6Storey RF, Angiolillo D J, Patil SB, et al. Inhibitory effects of tieagrelor compared with elopidogrel on platelet function in patients with acute coronary syndromes : the PLATO ( PLATelet inhibition and patient Outcomes ) PLATELET substudy. J Am Coil Cardio1,2010,56 : 1456-1462.

二级参考文献31

  • 1杜润,张瑞岩.晚期支架贴壁不良研究进展[J].国际心血管病杂志,2008,35(6):353-356. 被引量:4
  • 2中国成人血脂异常防治指南制定联合委员会.中国成人血脂异常防治指南[J].中华心血管病杂志,2007,:35-413,390.
  • 3de la Torre-Hernandez JM, Alfonso F, Hernandez F, et al. Drug-eluting stent thrombosis:results from the multicenter Spanish registry ESTRO- FA. J Am Coil Cardiol,2008 ,51:986-990.
  • 4Cutlip DE, Windecker S, Mehran R, et al. Clinical end points in coro- nary stent trials: a case for standardized definations. Circiulation, 2007,115:2344-2351.
  • 5Palmerini T, Dangas G, Mehran R, et al. Predictors and implications of stent thrombosis in non-ST-segment elevation acute coronary syn- dromes : the ACUITY TriM. Circ Cardiovasc Interv ,2011,4:577-584.
  • 6Kimura T, Morimoto T, Kozuma K, et al. Comparisons of baseline de- mographics, clinical presentation, and long-term outcome among pa- tients with early,late, and very late stent thrombosis of sirolimus-elu- ring stents : Observations from the Registry of Stent Thrombosis for Re- view and Reevaluation(RESTART). Circulation ,2010,122:52-61.
  • 7Dangas GD, Caixeta A, Mehran R, et al. Frequency and predictors of stent thrombosis after percutaneous coronary intervention in acute myo- cardial infarction. Circulation ,2011,123 : 1745-1756.
  • 8Heestermans AA, van Werkum JW, Zwart B, et al. Acute and subacute stent thrombosis after primary percutaneous coronary intervention for ST-segment elevation myocardial infarction : incidence, predictors and clinical outcome, j Thromb Haemost ,2010,8:2385-2393.
  • 9Kuchulakanti PK,Chu WW, Torguson R, et al. Correlates and long- term outcomes of angiographically proven stent thrombosis with siroli- mus-and paclitaxel-eluting stents. Circulation, 2006, 113 : 1108- 1113.
  • 10D' Ascenzo F, Bollati M, Clementi F, et al. Incidence and predictors of coronary stent thrombosis : Evidence from an international collabo- rative meta-analysis including 30 studies, 221,066 patients, and 4276 thromboses. Int J Cardiol,2012. [ Epub ahead of print].

共引文献83

同被引文献10

  • 1Nakano M,Yahagi K. Otsuka F. et al. Causes of early stent thrombosis in patients pI~senting with acute coronary syndrome: an ex vivo human autopsy study. J Am Coil Cardiol, 2014, 63 ( 23 ) : 2510-2520.
  • 2Schwartz BG, Khmer RA. Corona~' no reflow. J Mol Cell Cardiol, 2012, 52(4):873-882.
  • 3Ehnariah S, Jang IK. Acute stent ti~rombosis: technical complication or inadequate antithronfi~otie tt~erapy? An uptieal coherence tomography study. JACC Cardiovasc Interv, 2012, 5 (2) : e3-e4.
  • 4Dangas GD,Claessen BE, Mehran R, et al. Development and validation of a stent thrombosis risk score in patients with acute cnnmary syndromes. JACC Cardiovasc Inter',', 2012, 5 ( I 1 ) : 1097-1105.
  • 5Witzenbichler B. Maehara A, Weisz (,, el al. TCT-21 use of IVUS reduces stent thrombosis: results from the pn~spective, multicenter ADAPT-DES study. J Am Coil Cardiol, 2012, 60: B6-B7.
  • 6Parodi G, La Manna A, Di Vito L. et al. Stent-related defects in patients presenting with stent thrombosis: differences at optical coherence tomngraphy between subacute and late/very late thrombosis in the Mechanism Of Stent Thrombosis ( MOST ) study. Eun~lntervention, 2013. 9 (8) :936-944.
  • 7Gilard M,Barragan P, Not'yani AA, et al. 6- vel'sus 24-month dual antiplatelet therapy after implantation of drug-eluting stents in patients nonresistant to aspirin: the randomized, multicenter ITALIC trial. J Am Coil Caniiol, 2015, 65(8) :777-786.
  • 8Valenti R, Marcucci R, Comito V, et al. Prasugrel in clopido~cl nunresponders undergoing percutaneous eoronary intervention : the RECLOSE-3 study (Responsiveness to Clnpidogrel and Stent Thrombosis). JACC Cantiovasc luterv, 2015, 8 (12):1563- 1570.
  • 9Faber JE, Chilian WM, Deindl E, et al. A brief etymology of the collateral circulation. Arterioscler Thromb Vasc Biol, 2014, 34 (9) : I854-1859.
  • 10黄建波,袁战军,周建华,单文军,热娜.急性心肌梗塞急诊冠脉内支架植入后支架血栓形成的原因及处理[J].心血管康复医学杂志,2010,19(3):299-301. 被引量:12

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部